ID 3080 -
Papaya (CARICOL®)
PL: Papaya (CARICOL®)
EN: CARICOL® - Carica papaya (Common Name : Papaya)
Pdf: various food(s)/food constituent(s) not supported by pertinent human data
1.1. Zmniejszenie dolegliwości ze strony przewodu pokarmowego (ID 644, 1717, 1742, 1760, 2000, 2028, 2124, 2213, 2337, 3072, 3075, 3080, 3193, 4313)
The claimed effects are “digestive system”, “relief for gastric discomfort”, “zinc carnosine”, “relaxation”, “digestive health”, “liver health”, “digestion”, “healthy digestion”, “improvement of the digestion”, “santé gastro-intestinale”, and “digestive process/promotes intestinal well-being/can bind pathogenic bacteria/increases the activity of digestive enzymes”. The Panel assumes that the target population is the general population.
In the context of the proposed wordings and clarifications provided by Member States, the Panel assumes that the claimed effects refer to the reduction of gastro-intestinal discomfort.
The Panel considers that reduction of gastro-intestinal discomfort is a beneficial physiological effect.
2.1. Zmniejszenie dolegliwości ze strony przewodu pokarmowego (ID 644, 1717, 1742, 1760, 2000, 2028, 2124, 2213, 2337, 3072, 3075, 3080, 3193, 4313)
The references provided in relation to these claims were textbooks or narrative reviews which did not provide any original data which could be used for the scientific substantiation of the claim, or reported on animal or in vitro studies which addressed the effects of the food(s)/food constituent(s) on, e.g., spontaneous contractions of the jejunum, adhesion properties of Helicobacter pylori, pharmacologically or stress-induced gastric ulcers, necrotising enterocolitis, intestinal inflammation. One human intervention study which addressed the effects of the food(s)/food constituent(s) on the treatment of Helicobacter pylori infection was also provided. The Panel considers that no conclusions can be drawn from these references for the scientific substantiation of the claims.
No human studies which investigated the effects of the food(s)/food constituent(s) on measures of gastro-intestinal discomfort were provided in relation to any of the claims evaluated in this section.
The Panel concludes that a cause and effect relationship has not been established between the consumption of the food(s)/food constituent(s) which are the subject of the claims evaluated in this section and reduction of gastro-intestinal discomfort.
Warunki i możliwe ograniczenia stosowania oświadczenia
–Herstellung gemäß patentiertem Verfahren.––Tagesdosis–20-60ml–nach den Mahlzeiten.–
